Argo Blockchain
ARBK
Strategy
MSTR
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
US Stock MarketDetailed Quotes
OPT Opthea
- 5.210
- +0.050+0.97%
Close Feb 14 16:00 ET
- 5.210
- 0.0000.00%
Post 20:01 ET
801.75MMarket Cap-1.89P/E (TTM)
5.460High5.200Low13.30KVolume5.400Open5.160Pre Close70.43KTurnover0.01%Turnover RatioLossP/E (Static)153.89MShares6.30052wk High-10.57P/B511.76MFloat Cap1.79052wk Low--Dividend TTM98.23MShs Float16.230Historical High--Div YieldTTM5.04%Amplitude1.600Historical Low5.296Avg Price1Lot Size
About Opthea Company
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.
Company Profile
SymbolOPT
Company NameOpthea
Issue Price13.50
Founded1984
CEODr. Frederic Guerard, Pharm.D.
MarketNASDAQ
Employees34
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends06-30
Address650 Chapel Street,Suite 0403,Level 4
CitySouth Yarra
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3141
Phone61-3-9826-0399
Websitehttp://www.opthea.com
Company Executives
- Name
- Position
- Salary
- Dr. Frederic Guerard, Pharm.D.
- Chief Executive Officer
- 1.32M
- Peter F. Lang
- Chief Financial Officer
- 1.16M
- Dr. Megan Baldwin
- Chief Innovation Officer and Executive Director
- 1.36M
- Judith J. Robertson
- Chief Commercial Officer
- 715.10K
- Kevin Bitter
- Vice President, Strategy & Corporate Development
- --
- Mark O Neill
- Vice President, Chemistry, Manufacturing and Controls
- --
- Dr. John Han
- Vice President, Medical Affairs
- --
- Julie Clark
- Senior Vice President, Clinical Development
- --
- Fang Li, PhD
- Senior Vice President, Regulatory
- --
- Karen Adams
- Vice President, Finance and Company Secretary
- 466.17K
- Bruno Gagnon
- Senior Vice President, Global Clinical Operations
- --
- Jeremy M. Levin, D.Phil.,M.B.
- Chairman of the Board
- 309.43K
- Anshul Thakral
- Director
- 103.72K
- Dr. Julia A. Haller, M.D.
- Director
- 170.25K
- Sujal Shah
- Independent Director
- 16.72K
- Lawrence B. Gozlan
- Independent Director
- 790.52K
- Susan Orr
- Independent Director
- 130.26K
- Quinton Oswald
- Independent Director
- 135.81K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.